ARE LABS / RESEARCH
Explore the questions we investigated, the measurements we made and what the results mean for product development.
4 studies found
Inhalation & Drug Delivery
The study established an early performance baseline for comparing the two variants and provided data for a regulatory-facing Phase 1 characterization package. It did not assess clinical efficacy or support claims of approval.
Selected findingRecovered material was predominantly classified in the nasal or upper-airway region for both variants.
Aerosol Characterization
The study compared the tested fragrance aerosols by spray particle-size distribution and time-resolved chamber counts under defined conditions.
Selected findingGroup-average D[4,3] was 31.49 µm for Test Article A and 75.03-89.77 µm for Comparator groups B-D.
Exposure Assessment
The work helped the client answer the relevant inhalation exposure question instead of relying on a broad bulk-material screen.
Selected findingThe method focused on the respirable aerosol fraction of the powder rather than total TiO2 in the compact.
Facilities
The client needed a measured baseline for surface particle accumulation across operating spaces, with enough spatial detail to compare buildings, halls, and sampling heights.
Selected findingAcross 123 primary slides, mean and median mass deposition rates were 14.7 and 7.5 mg/m²/day.